Oric Pharmaceuticals Stock Market Value
| ORIC Stock | USD 10.26 0.50 4.65% |
| Symbol | Oric |
Will Biotechnology sector continue expanding? Could Oric diversify its offerings? Factors like these will boost the valuation of Oric Pharmaceuticals. Anticipated expansion of Oric directly elevates investor willingness to pay premium valuations. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Oric Pharmaceuticals data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Oric Pharmaceuticals's market price often diverges from its book value, the accounting figure shown on Oric's balance sheet. Smart investors calculate Oric Pharmaceuticals' intrinsic value—its true economic worth—which may differ significantly from both market price and book value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Since Oric Pharmaceuticals' trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
It's important to distinguish between Oric Pharmaceuticals' intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Oric Pharmaceuticals should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. However, Oric Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Oric Pharmaceuticals 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Oric Pharmaceuticals' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Oric Pharmaceuticals.
| 11/02/2025 |
| 01/31/2026 |
If you would invest 0.00 in Oric Pharmaceuticals on November 2, 2025 and sell it all today you would earn a total of 0.00 from holding Oric Pharmaceuticals or generate 0.0% return on investment in Oric Pharmaceuticals over 90 days. Oric Pharmaceuticals is related to or competes with Amylyx Pharmaceuticals, Relay Therapeutics, Precigen, Nektar Therapeutics, Inhibrx Biosciences, Syndax Pharmaceuticals, and Terns Pharmaceuticals. ORIC Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for treatment o... More
Oric Pharmaceuticals Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Oric Pharmaceuticals' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Oric Pharmaceuticals upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.1) | |||
| Maximum Drawdown | 20.28 | |||
| Value At Risk | (4.65) | |||
| Potential Upside | 6.63 |
Oric Pharmaceuticals Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Oric Pharmaceuticals' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Oric Pharmaceuticals' standard deviation. In reality, there are many statistical measures that can use Oric Pharmaceuticals historical prices to predict the future Oric Pharmaceuticals' volatility.| Risk Adjusted Performance | (0.06) | |||
| Jensen Alpha | (0.37) | |||
| Total Risk Alpha | (0.53) | |||
| Treynor Ratio | (0.40) |
Oric Pharmaceuticals January 31, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.06) | |||
| Market Risk Adjusted Performance | (0.39) | |||
| Mean Deviation | 2.77 | |||
| Coefficient Of Variation | (1,145) | |||
| Standard Deviation | 3.81 | |||
| Variance | 14.52 | |||
| Information Ratio | (0.1) | |||
| Jensen Alpha | (0.37) | |||
| Total Risk Alpha | (0.53) | |||
| Treynor Ratio | (0.40) | |||
| Maximum Drawdown | 20.28 | |||
| Value At Risk | (4.65) | |||
| Potential Upside | 6.63 | |||
| Skewness | 0.6247 | |||
| Kurtosis | 1.74 |
Oric Pharmaceuticals Backtested Returns
Oric Pharmaceuticals maintains Sharpe Ratio (i.e., Efficiency) of -0.0699, which implies the firm had a -0.0699 % return per unit of risk over the last 3 months. Oric Pharmaceuticals exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check Oric Pharmaceuticals' Risk Adjusted Performance of (0.06), coefficient of variation of (1,145), and Variance of 14.52 to confirm the risk estimate we provide. The company holds a Beta of 0.86, which implies possible diversification benefits within a given portfolio. Oric Pharmaceuticals returns are very sensitive to returns on the market. As the market goes up or down, Oric Pharmaceuticals is expected to follow. At this point, Oric Pharmaceuticals has a negative expected return of -0.27%. Please make sure to check Oric Pharmaceuticals' treynor ratio, accumulation distribution, price action indicator, as well as the relationship between the potential upside and day median price , to decide if Oric Pharmaceuticals performance from the past will be repeated at some point in the near future.
Auto-correlation | -0.69 |
Very good reverse predictability
Oric Pharmaceuticals has very good reverse predictability. Overlapping area represents the amount of predictability between Oric Pharmaceuticals time series from 2nd of November 2025 to 17th of December 2025 and 17th of December 2025 to 31st of January 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Oric Pharmaceuticals price movement. The serial correlation of -0.69 indicates that around 69.0% of current Oric Pharmaceuticals price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.69 | |
| Spearman Rank Test | -0.72 | |
| Residual Average | 0.0 | |
| Price Variance | 2.61 |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Oric Pharmaceuticals offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Oric Pharmaceuticals' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Oric Pharmaceuticals Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Oric Pharmaceuticals Stock:Check out Oric Pharmaceuticals Correlation, Oric Pharmaceuticals Volatility and Oric Pharmaceuticals Performance module to complement your research on Oric Pharmaceuticals. For information on how to trade Oric Stock refer to our How to Trade Oric Stock guide.You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.
Oric Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.